Evidence map›Paper›PMID 42985366›Full record

ArticleAdvances in pharmacological and pharmaceutical sciences2026

Hydroxychavicol-Rich

Siti Marliana Jasni, Yiizamy Suffian, Nor Hisam Zamakshshari, Erna-Zulaikha Dayang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in pharmacological and pharmaceutical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Siti Marliana JasniDepartment of Paraclinical Sciences Faculty of Medicine and Health Sciences Universiti Malaysia Sarawak 94300 Kota Samarahan Sarawak Malaysia unimas.my.ORCID https://orcid.org/0009-0004-1384-2642
Yiizamy SuffianDepartment of Chemistry Faculty of Resource Science and Technology Universiti Malaysia Sarawak 94300 Kota Samarahan Sarawak Malaysia unimas.my.ORCID https://orcid.org/0009-0007-2661-8705
Nor Hisam ZamakshshariDepartment of Chemistry Faculty of Resource Science and Technology Universiti Malaysia Sarawak 94300 Kota Samarahan Sarawak Malaysia unimas.my.ORCID https://orcid.org/0000-0003-1838-5116
Erna-Zulaikha DayangDepartment of Paraclinical Sciences Faculty of Medicine and Health Sciences Universiti Malaysia Sarawak 94300 Kota Samarahan Sarawak Malaysia unimas.my.ORCID https://orcid.org/0000-0001-9543-1556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerosis is a chronic inflammatory disorder that involves endothelial dysfunction and accumulation of inflammatory cells in the vessel intima. Approximately 32% of global mortality is attributed to cardiovascular diseases, with atherosclerosis playing a major role. Endothelial dysfunction is a key hallmark of atherosclerosis, with key mediator tumor necrosis factor-α (TNF-α) driving endothelial-monocyte interactions that further lead to adverse cardiovascular events. Hydroxychavicol, a phenolic compound enriched in

Indexed as

adhesion moleculesatherosclerosiscytokinesinflammationPiper betleTNF-α

Identifiers

PMID42985366
PMCPMC13731973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.